Sarmiento, Evelyn .
HRN: 26-95-46 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2025
CEFUROXIME 750MG (VIAL)
11/20/2025
11/26/2025
IV
1.5g
Q8
Placenta Previa
Checking Initial Appropriateness
11/20/2025
CEFUROXIME 1.5GM (VIAL)
11/20/2025
11/21/2025
1.5G
Ivtt
Q8h
SP LTCS
Checking Initial Appropriateness
11/20/2025
CEFUROXIME 500MG (TAB)
11/21/2025
11/27/2025
PO
500mg
BID
SP LTCS
Checking Initial Appropriateness